Suchergebnisse - "Hasselbalch, Hans Carl"

PubPharm (236)

31

Patients with myeloproliferative neoplasms and high levels of systemic inflammation develop age-related macular degeneration

enthalten in: EClinicalMedicine | 2020

von Liisborg, C. | Nielsen, M. | Hasselbalch, H. | +1

32

Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis : a phase II study

enthalten in: Haematologica | 2020

von Sørensen, A. | Mikkelsen, S. | Knudsen, T. | +17

CommentIn: Haematologica. 2020 Jun 05;105(9):2190-2191. - PMID 33054041

33

Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms

enthalten in: Cancers | 2020

von Holmström, M. | Hasselbalch, H. | Andersen, M.

34

Rationales for using JAK 1/2 inhibitors in severely afflicted patients with COVID-19 pneumonia

enthalten in: Ugeskrift for laeger | 2020

von Hasselbalch, H. | Poulsen, A. | Skov, V. | +3

35

Myeloproliferative neoplasms and chronic inflammatory bowel disease

enthalten in: Ugeskrift for laeger | 2020

von Hesselø, H. | Bak, M. | Boysen, T. | +2

36

Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm

enthalten in: EClinicalMedicine | 2020

von Pedersen, K. | Çolak, Y. | Hasselbalch, H. | +2

37

Loss-of-function polymorphism in IL6R reduces risk of JAK2V617F somatic mutation and myeloproliferative neoplasm : A Mendelian randomization study

enthalten in: EClinicalMedicine | 2020

von Pedersen, K. | Çolak, Y. | Ellervik, C. | +3

38

Two-fold risk of pneumonia and respiratory mortality in individuals with myeloproliferative neoplasm : A population-based cohort study

enthalten in: EClinicalMedicine | 2020

von Pedersen, K. | Çolak, Y. | Hasselbalch, H. | +3

39

Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms

enthalten in: Cancers | 2020

von Liisborg, C. | Hasselbalch, H. | Sørensen, T.

40

Evidence of immune elimination, immuno-editing and immune escape in patients with hematological cancer

enthalten in: Cancer immunology, immunotherapy : CII | 2020

von Holmström, M. | Cordua, S. | Skov, V. | +5